Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christine Favre is active.

Publication


Featured researches published by Christine Favre.


Archive | 2007

Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent

Christine Favre; Michel Auguet; Pierrre-Etienne Chabrier De Lassauniere


Archive | 2007

Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative

Michel Auguet; Christine Favre; Pierre-Etienne Chabrier de Lassauniere


Archive | 2007

Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the aids virus

Christine Favre; Michel Auguet; Pierre-Etienne Chabrier de Lassauniere


Archive | 2009

Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy

Christine Favre; Michel Auguet; Piere-Etienne Chabrier De Lassauniere


Archive | 2009

Therapeutic Use of Botulinum Neurotoxin in the Treatment of pain associated with diabetic neuropathy

Christine Favre; Michel Auguet; De Lassauniere Pierre-Etienne Chabrier


Archive | 2009

Therapeutische verwendung von mindestens einem botulinneurotoxin zur behandlung von schmerz im zusammenhang mit diabetischer neuropathie

Christine Favre; Michel Auguet; De Lassauniere Pierre-Etienne Chabrier


Archive | 2009

Therapeutische verwendung von botulinneurotoxin typ a zur behandlung von schmerz im zusammenhang mit diabetischer neuropathie

Christine Favre; Michel Auguet; De Lassauniere Pierre-Etienne Chabrier


Archive | 2009

Utilisation thérapeutique d'au moins une neurotoxine botulinique dans le traitement de la douleur associée à une neuropathie diabétique

Christine Favre; Michel Auguet; De Lassauniere Pierre-Etienne Chabrier


Archive | 2008

Therapeutic use of at least one botulinum neurotoxin in the treatment of pain in the case of diabetic neuropathy

Christine Favre; Michel Auguet; De Lassauniere Pierre-Etienne Chabrier


Archive | 2007

Gleichzeitige, separate oder sequentielle verwendung mindestens eines botulinus-neurotoxins und mindestens eines opiat-derivats

Michel Auguet; Christine Favre; De Lassauniere Pierre-Etienne Chabrier

Researchain Logo
Decentralizing Knowledge